Industry Insiders Overwhelmingly Agree, The Price of Biogen’s Aducanumab Is “Borderline Fraud”
Survey Respondents Said “This is Not Science or Healthcare, This is Corporate Greed,” Called Biogen’s…
protectourcareJune 10, 2021